Steven Thoma, MD
Urology · Mason City, IANPI 1598021131
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,014 of the $4,654 with a category attached, or 64.8%. 33 manufacturers reported payments, led by Teleflex LLC at 58.6% of the total. Reporting peaked in 2022 at $1,565 and has fallen 70.0% since, to $469 in 2025.
Across 124 payments — averaging $37.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teleflex LLC$3K
- Sumitomo Pharma America, Inc.$282
- Urogen Pharma, Inc.$260
- Johnson & Johnson$203
- Boston Scientific$133
- Coloplast$113
- plus $937 from 27 others
What the payments were for
- Travel & lodging$1,63935%
- Food & beverage$3,01465%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teleflex LLC | 24 | $2,725 |
| Sumitomo Pharma America, Inc. | 20 | $282 |
| Urogen Pharma, Inc. | 10 | $260 |
| Johnson & Johnson | 11 | $203 |
| Boston Scientific | 3 | $133 |
| Coloplast | 7 | $113 |
| AbbVie | 6 | $105 |
| Procept Biorobotics Corporation | 1 | $68 |
| 180 Medical, Inc. | 3 | $66 |
| Conmed Corporation | 2 | $57 |
| Intuitive Surgical | 1 | $56 |
| Dendreon Pharmaceuticals LLC | 3 | $55 |
| Axonics, Inc. | 3 | $49 |
| Progenics Pharmaceuticals, Inc. | 3 | $48 |
| Merck | 3 | $47 |
| Tolmar Pharmaceuticals, Inc. | 2 | $37 |
| Urovant Sciences Inc | 3 | $36 |
| Inspire Medical Systems, Inc. | 2 | $35 |
| Integra Lifesciences Corporation | 2 | $31 |
| Neotract Inc. | 2 | $27 |
| Palette Life Sciences, Inc. | 1 | $26 |
| Abbott | 1 | $23 |
| Convatec Inc. | 1 | $21 |
| AstraZeneca | 1 | $21 |
| Accord Healthcare, Inc. | 1 | $18 |
| Tolmar, Inc. | 1 | $16 |
| Laborie Medical Technologies Corp. | 1 | $16 |
| Bayer | 1 | $16 |
| Myovant Sciences Inc. | 1 | $14 |
| Astellas Pharma US Inc | 1 | $13 |
| Endo Pharmaceuticals Inc. | 1 | $13 |
| Cook Medical LLC | 1 | $12 |
| Healthtronics Stone Solutions, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UroLift$1,203
- UroLift System$965
- SPACEOAR VUE$102
How this compares
$4,654 in reported general payments places this provider in the 70th percentile of 114 urology providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 191 | $95,390 |
| MyrbetriqMirabegron | 155 | $78,631 |
| Oxybutynin Chloride ErOxybutynin Chloride | 219 | $4,531 |
| Tamsulosin Hcl | 576 | $4,213 |
| NitrofurantoinNitrofurantoin Macrocrystal | 98 | $1,703 |
| Finasteride | 216 | $1,690 |
| Potassium Citrate ErPotassium Citrate | 28 | $1,152 |
| Ciprofloxacin Hcl | 176 | $911 |
| Testosterone Cypionate | 22 | $536 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 17 | $352 |
| Oxybutynin Chloride | 19 | $350 |
| Cephalexin | 47 | $199 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 33 | $197 |
| Solifenacin Succinate | 15 | $122 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 15 | $95 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $282 | $95,390191 claims |
| Astellas Pharma US IncMyrbetriq | $13 | $78,631155 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 114 urology providers in Iowa.
Other urology in Mason City
- Elizabeth TakacsMason City$4K
- Timothy MulhollandMason City$3K
- Kevin RierMason City$2K
- Christopher AdamsMason City$1K
- Vignesh PackiamIowa City$112K
- Annah VollstedtIowa City$66K
- Bradley EricksonIowa City$65K
- Michael OdonnellIowa City$62K
- Kevin BirusinghDes Moines$59K
- Ryan DornbierClive$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.